Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
105,337,747
-
Total 13F shares
-
50,239,434
-
Share change
-
+2,210,893
-
Total reported value
-
$767,640,710
-
Price per share
-
$15.28
-
Number of holders
-
56
-
Value change
-
+$33,441,771
-
Number of buys
-
40
-
Number of sells
-
10
Institutional Holders of Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (EWTX) as of Q4 2021
As of 31 Dec 2021,
Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (EWTX) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,239,434 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Novo Holdings A/S, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Cormorant Asset Management, LP, VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P., FMR LLC, CITADEL ADVISORS LLC, BlackRock Inc., and New Leaf Venture Partners, L.L.C..
This page lists
56
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.